159885-80-0 Usage
Uses
Used in Pharmaceutical Research:
1-(4-Phenyl-thiazol-2-yl)-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid is used as a research compound for exploring its potential in drug discovery and development. Its complex structure and the presence of a carboxylic acid group make it a candidate for further investigation into its pharmacological properties and possible therapeutic applications.
Used in Chemical Synthesis:
In the field of organic chemistry, 1-(4-Phenyl-thiazol-2-yl)-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid is used as a building block or intermediate in the synthesis of more complex molecules. Its unique structure and functional groups can be exploited to create novel compounds with potential applications in various industries.
Used in Material Science:
1-(4-Phenyl-thiazol-2-yl)-5-trifluoromethyl-1H-pyrazole-4-carboxylic acid may also find applications in material science, where its properties can be utilized to develop new materials with specific characteristics. The trifluoromethyl group, in particular, could contribute to the creation of materials with altered physical or chemical properties, such as enhanced stability or reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 159885-80-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,8,8 and 5 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 159885-80:
(8*1)+(7*5)+(6*9)+(5*8)+(4*8)+(3*5)+(2*8)+(1*0)=200
200 % 10 = 0
So 159885-80-0 is a valid CAS Registry Number.
159885-80-0Relevant articles and documents
Novel thiazole-based heterocycles as selective inhibitors of fibrinogen- mediated platelet aggregation
Sanfilippo,Urbanski,Beers,Eckardt,Falotico,Ginsberg,Offord,Press,Tighe,Tomko,Andrade-Gordon
, p. 34 - 41 (2007/10/02)
The synthesis and biological activity of novel thiazole-based heterocycles as inhibitors of thrombin-induced human platelet aggregation are described. Further evaluation of selected compounds show they inhibit platelet aggregation as stimulated by a varie